Mercer Global Advisors Inc Marker Therapeutics, Inc. Transaction History

Mercer Global Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.26 - $0.46 $11,700 - $20,700	-45,000 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$0.37 - $1.0 $16,650 - $45,000	45,000 New	45,000 $20,000
Q4 2020 Feb 12, 2021	SELL	$1.36 - $1.75 $31,182 - $40,124	-22,928 Closed	0 $0
Q3 2020 Dec 10, 2020	BUY	$1.5 - $2.2 $34,392 - $50,441	22,928 New	22,928 $34,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $278M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.